← Evidence map

ArticleHemaSphere2025

Mitigation of atrial fibrillation-related complications with antithrombotic and cytoreductive therapy in patients with Myeloproliferative Neoplasms: Implications from the GSG-MPN bioregistry.

Hyunyee Rosa Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Mitigation of atrial fibrillation-related complications with antithrombotic and cytoreductive therapy in patients with Myeloproliferative Neoplasms: Implications from the GSG-MPN bioregistry. | OpenQuestion